{"id":"doi:10.1002/alz.14313","kind":"article","title":"Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US","authors":["William Yang Wang","QuangQiu Wang","Xin Qi","Mark E. Gurney","George L. Perry","Nora D. Volkow","Pamela B. Davis","David C. Kaelber","Rong Xu"],"author_count":9,"year":2024,"published":"2024-10-24","venue":"Alzheimer s & Dementia","cited_by":180,"doi":"10.1002/alz.14313","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1002/alz.14313","archive_url":"https://space-kitty.com/papers/doi:10.1002/alz.14313","updated":null,"pmid":"39445596","pmcid":null,"openalex_id":"W4403703331","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14313","abstract":null,"abstract_license":null,"license":"cc-by-nc-nd","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Diabetes Treatment and Management"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}